CHEK1 was also used in zhang's study as a hub gene and new biomarker for IDD [20], a serine/threonine-specific protein kinase that regulates the DNA damage response and cell cycle checkpoint response and influences tumour development through both of these [21]. The gene discussed is DYRK1A; the disease is neoplasm.